Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.
Gelmetix
Medical device company
Company information
Company:
Private
Fund:
EIS Portfolio Service
Sector:
Medical, Pharma
Status:
Current
Investment Date:
10/2019
You might also be interested in...
Highly accredited engineering consultancy providing high-impact work package solutions for critical military platforms
Developer of novel aptamers for research, diagnostic and therapeutic purposes